RAYMOND JAMES & ASSOCIATES - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$23,052
+117.1%
20,221
+74.3%
0.00%
Q2 2023$10,616
+112.3%
11,602
-10.1%
0.00%
Q2 2022$5,000
-44.4%
12,9000.0%0.00%
Q1 2022$9,000
-83.0%
12,900
-44.9%
0.00%
Q4 2021$53,000
-17.2%
23,400
+4.5%
0.00%
Q3 2021$64,000
-24.7%
22,3950.0%0.00%
Q2 2021$85,000
+13.3%
22,395
+1.0%
0.00%
Q1 2021$75,000
+31.6%
22,171
+8.8%
0.00%
Q4 2020$57,000
+111.1%
20,371
+91.8%
0.00%
Q3 2020$27,000
-87.0%
10,621
-30.4%
0.00%
Q2 2020$207,000
+95.3%
15,266
+9.6%
0.00%
Q1 2020$106,000
+2.9%
13,935
-14.6%
0.00%
Q4 2019$103,000
+22.6%
16,309
-23.6%
0.00%
Q3 2019$84,000
-10.6%
21,352
+9.5%
0.00%
Q2 2019$94,000
-75.6%
19,500
-49.6%
0.00%
-100.0%
Q2 2018$386,000
+4.6%
38,698
-0.2%
0.00%0.0%
Q1 2018$369,000
-37.2%
38,761
-2.0%
0.00%0.0%
Q4 2017$588,000
-18.9%
39,559
+7.4%
0.00%0.0%
Q3 2017$725,000
+38.1%
36,838
+0.9%
0.00%0.0%
Q2 2017$525,000
+58.6%
36,517
+1.4%
0.00%0.0%
Q1 2017$331,000
-6.0%
35,998
+6.5%
0.00%0.0%
Q4 2016$352,000
+35.4%
33,814
+17.6%
0.00%0.0%
Q3 2016$260,000
+51.2%
28,746
+25.3%
0.00%0.0%
Q2 2016$172,000
-17.7%
22,937
-1.0%
0.00%0.0%
Q1 2016$209,000
-32.4%
23,165
-3.2%
0.00%0.0%
Q4 2015$309,00023,9290.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$13,027,0005.13%
Orchard Capital Management, LLC 857,138$2,400,0001.02%
Nantahala Capital Management 7,040,487$19,713,0000.61%
OCCUDO QUANTITATIVE STRATEGIES LP 209,040$585,0000.18%
Woodline Partners LP 2,382,522$6,671,0000.18%
RICE HALL JAMES & ASSOCIATES, LLC 1,546,169$4,329,0000.15%
Virtus ETF Advisers LLC 92,771$260,0000.11%
Jump Financial, LLC 155,583$435,0000.07%
GSA CAPITAL PARTNERS LLP 128,626$360,0000.06%
Anson Funds Management LP 95,342$267,0000.05%
View complete list of AKEBIA THERAPEUTICS INC shareholders